-
Loading metrics
Oral Administration of PF-01247324, a Subtype-Selective Nav1.8 Blocker, Reverses Cerebellar Deficits in a Mouse Model of Multiple Sclerosis
- Shannon D. Shields,
- Richard P. Butt,
- Sulayman D. Dib-Hajj,
- Stephen G. Waxman
x
- Published: March 6, 2015
- https://doi.org/10.1371/journal.pone.0119067